Citation Impact

Citing Papers

Postconditioning the Human Heart
2005
Hypoxia-Inducible Factors in Physiology and Medicine
2012 StandoutNobel
ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
2007
Determinants of collateral filling observed during sudden controlled coronary artery occlusion in human subjects
1989
Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials
2003 Standout
Ischemic stroke and intracranial hemorrhage following thrombolytic therapy for acute myocardial infarction: A risk-benefit analysis
1992
Surviving ischemia: adaptive responses mediated by hypoxia-inducible factor 1
2000 StandoutNobel
Nicorandil improves cardiac function and clinical outcome in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: Role of inhibitory effect on reactive oxygen species formation
2004
Circulating Endothelial Progenitor Cells and Cardiovascular Outcomes
2005 Standout
Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction
1992 Standout
Prospects for Cardiovascular Research
2001 StandoutNobel
Selection of Patients with Acute Myocardial Infarction for Thrombolytic Therapy
1990
Bivalirudin during Primary PCI in Acute Myocardial Infarction
2008 Standout
Factors affecting sensitivity and specificity of a diagnostic test: the exercise thallium scintigram
1988
Improved thrombolysis with a modified dose regimen of recombinant tissue-type plasminogen activator
1989
Intracoronary Bone Marrow–Derived Progenitor Cells in Acute Myocardial Infarction
2006 Standout
Morphologic and dynamic changes of atherosclerotic plaque at the carotid artery bifurcation: Sequential imaging by real time B-mode ultrasonography
1988
Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts
2004 StandoutNature
Adult Cardiac Stem Cells Are Multipotent and Support Myocardial Regeneration
2003 Standout
Standardized Myocardial Segmentation and Nomenclature for Tomographic Imaging of the Heart
2002 Standout
Hemostatic Factors and the Risk of Myocardial Infarction or Sudden Death in Patients with Angina Pectoris
1995 Standout
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
2009 Standout
Coronary heart disease: seven dietary factors
1991 Standout
Expression of Vascular Endothelial Growth Factor Receptor 1 in Bone Marrow-derived Mesenchymal Cells Is Dependent on Hypoxia-inducible Factor 1
2006 StandoutNobel
Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction
1992 StandoutNature
A Prospective Natural-History Study of Coronary Atherosclerosis
2011 Standout
Gene therapy for myocardial angiogenesis
1999
Antioxidants and Atherosclerotic Heart Disease
1997 Standout
A randomized study of intravenous magnesium in acute myocardial infarction treated with direct coronary angioplasty
2000
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
1992 Standout
Comparison of intravenous urokinase plus heparin versus heparin alone in acute myocardial infarction
1991
Hypoxia-Inducible Factor 1α Polymorphism and Coronary Collaterals in Patients With Ischemic Heart Disease
2005 StandoutNobel
The efficacy of a ‘master switch gene’ HIF-1α in a porcine model of chronic myocardial ischaemia
2005
Initiation of Platelet Adhesion by Arrest onto Fibrinogen or Translocation on von Willebrand Factor
1996 Standout
Guidelines for Percutaneous Coronary Interventions
2005
Atherosclerosis — An Inflammatory Disease
1999 Standout
Angiographic progression of coronary artery disease and the development of myocardial infarction
1988
Myocardial Reperfusion Injury
2007 Standout
Transcoronary Transplantation of Progenitor Cells after Myocardial Infarction
2006 Standout
Thrombolysis and Angioplasty in Myocardial Infarction (TAMI-1) trial: Influence of infarct location on arterial patency, left ventricular function and mortality
1989
Tomographic imaging using the nonlinear response of magnetic particles
2005 StandoutNature
Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study
2001 Standout
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
1992 Standout
Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy Men
1997 Standout
Simultaneous assessment of myocardial perfusion and left ventricular function during transient coronary occlusion
1995
Oxygen Sensing, Homeostasis, and Disease
2011 StandoutNobel
Adoption of thrombolytic therapy in the management of acute myocardial infarction
1988
Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial
2004 Standout
The pathogenesis of atherosclerosis: a perspective for the 1990s
1993 StandoutNature
External validity of randomised controlled trials: “To whom do the results of this trial apply?”
2005 Standout
Angiogenesis as a therapeutic target
2005 StandoutNature
Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS)
1996 Standout
Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes
2007 Standout
Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients
1994 Standout
The Coronary Angiogram and Its Seminal Contributions to Cardiovascular Medicine Over Five Decades
2002
A prospective, randomized trial comparing combination half-dose tissue-type plasminogen activator and streptokinase with full-dose tissue-type plasminogen activator. Kentucky Acute Myocardial Infarction Trial (KAMIT) Group.
1991
Guidelines for the early management of patients with acute myocardial infarction
1990
Hypoxia-inducible factor 1α protein expression is controlled by oxygen-regulated ubiquitination that is disrupted by deletions and missense mutations
2000 StandoutNobel
Coronary Thrombolysis for Evolving Myocardial Infarction
1984
Dietary n-3 polyunsaturated fatty acids and amelioration of cardiovascular disease: possible mechanisms
1990
Plaque rupture with severe pre-existing stenosis precipitating coronary thrombosis. Characteristics of coronary atherosclerotic plaques underlying fatal occlusive thrombi.
1983
Prevalence of Total Coronary Occlusion during the Early Hours of Transmural Myocardial Infarction
1980 Standout
Paradoxic elevation of fibrinopeptide A after streptokinase: Evidence for continued thrombosis despite intense fibrinolysis
1987
Measurement of Fractional Flow Reserve to Assess the Functional Severity of Coronary-Artery Stenoses
1996 Standout
Factors influencing probability of reperfusion with intracoronary ostial infusion of thrombolytic agent in patients with acute myocardial infarction.
1985
Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI)
2002 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines)31This document was approved by the American College of Cardiology Board of Trustees in April 2001 and by the American Heart Association Science Advisory and Coordinating Committee in March 2001.32When citing this document, the American College of Cardiology and the American Heart Association would appreciate the following citation format: Smith SC, Jr, Dove JT, Jacobs AK, Kennedy JW, Kereiakes D, Kern MJ, Kuntz RE, Popma JJ, Schaff HV, Williams DO. ACC/AHA guidelines for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1993 Guidelines for Percutaneous Transluminal Coronary Angioplasty). J Am Coll Cardiol 2001;37:2239i–lxvi.33This document is available on the ACC Web site at www.acc.organd the AHA Web site at www.americanheart.org(ask for reprint no. 71-0206). To obtain a reprint of the shorter version (executive summary and summary of recommendations) to be published in the June 15, 2001 issue of the Journal of the American College of Cardiology and the June 19, 2001 issue of Circulation for $5 each, call 800-253-4636 (US only) or write the American College of Cardiology, Educational Services, 9111 Old Georgetown Road, Bethesda, MD 20814-1699. To purchase additional reprints up to 999 copies, call 800-611-6083 (US only) or fax 413-665-2671; 1,000 or more copies, call 214-706-1466, fax 214-691-6342, or E-mail: pubauth@heart.org(ask for reprint no. 71-0205).
2001
An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial Infarction
1993 Standout
IMPROVED SURVIVAL AFTER EARLY THROMBOLYSIS IN ACUTE MYOCARDIAL INFARCTION
1985
Cardiac progenitor cells from adult myocardium: Homing, differentiation, and fusion after infarction
2003 Standout
Western Washington Randomized Trial of Intracoronary Streptokinase in Acute Myocardial Infarction
1983
EFFECTIVENESS OF INTRAVENOUS THROMBOLYTIC TREATMENT IN ACUTE MYOCARDIAL INFARCTION
1986 Standout
Adenoviral transfer of HIF-1α enhances vascular responses to critical limb ischemia in diabetic mice
2009 StandoutNobel
Clinicopathologic correlates of acute ischemic heart disease syndromes
1981
Increased thrombin levels during thrombolytic therapy in acute myocardial infarction. Relevance for the success of therapy.
1991
Effect of Intravenous Streptokinase on Acute Myocardial Infarction
1982
Lewis A. Conner Memorial Lecture. Mechanisms leading to myocardial infarction: insights from studies of vascular biology.
1994
ACC/AHA Guidelines for Percutaneous Coronary Intervention (Revision of the 1993 PTCA Guidelines)—Executive Summary
2001
Thrombolytic therapy with tissue plasminogen activator or streptokinase induces transient thrombin activity
1988
Weekend versus Weekday Admission and Mortality from Myocardial Infarction
2007 Standout
Hypoxia-inducible factor 1 transcriptional activity in endothelial cells is required for acute phase cardioprotection induced by ischemic preconditioning
2012 StandoutNobel
2012 ACCF/AHA Focused Update Incorporated Into the ACCF/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
2013
Meta-analysis in clinical trials
1986 Standout

Works of H. Blanke being referenced

Die Bedeutung des Thrombin-Antithrombin III-Komplexes in der Diagnostik der Lungenembolie und der tiefen Venenthrombose — Vergleich mit Fibrinopeptid A, Plättchenfaktor 4 und β-Thromboglobulin
1987
Prevalence and significance of residual flow to the infarct zone during the acute phase of myocardial infarction
1985
Evaluation of the effectiveness of intracoronary streptokinase infusion in acute myocardial infarction: Postprocedure management and hospital course in 204 patients
1981
Acute myocardial infarction: Intracoronary application of nitroglycerin and streptokinase
1979
[Results of quantitative myocardial scintigraphy with thallium-201 at rest and after maximum exercise--critical analysis of predictive value and clinical application (author's transl)].
1980
Percutaneous transluminal coronary recanalization: Procedure, results, and acute complications
1981
Initial experience with transluminal recanalization of the recently occluded infarct‐related coronary artery in acute myocardial infarction — Comparison with conventionally treated patients
1979
Recanalization of an acutely occluded aortocoronary bypass by intragraft fibrinolysis.
1980
Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects
1985
Changes in left ventricular function after intracoronary streptokinase infusion in clinically evolving myocardial infarction
1981
Selective intracoronary thrombolysis in acute myocardial infarction and unstable angina pectoris.
1981
Wiedereröffnung verschlossener Kranzgefäße im akuten Infarkt mit Hilfe von Kathetern
1979
Rankless by CCL
2026